Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Nanoviricides, Inc. NNVC US Equity

Health Care · CIK 1379006 · FY ends Jun 30
$1.24
-0.04 (-3.13%)
USD · as of 2026-08-28 · marketstack

Nanoviricides, Inc. (NYSE: NNVC), an SEC filer in Pharmaceutical Preparations, closed at $1.24, -3.1%, on 2026-08-28, with a market cap of $28M as of 2026-08-27 and a return on equity of -99.7%. Institutional ownership, earnings history and filed financials are on the tabs below.

Legal & controls

5 of 5 annual reports readable here

Item 3 and Item 9A as filed · every verdict is the registrant’s own sentence, printed below it · a filing that fails an extraction gate reads “not extracted”

Fiscal yearFiledItem 3ICFRdisclosure controlsmaterial weaknessFiling
2025-06-302025-09-29none statedeffectiveeffectivenone in Item 9AEDGAR

Item 3 · From time to time, we are a party to legal proceedings arising in the ordinary course of business. We are not currently a party to any legal proceedings that we believe could have a material adverse effect on financial condition or results of operations.

Item 9A · ICFR · Based on our evaluation under this framework, our management concluded that our internal control over financial reporting was effective as of June 30, 2025.

Item 9A · disclosure controls · Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures are effective as of June 30, 2025.

2024-06-302024-09-27none statedeffectiveeffectiveremediated (prior year)EDGAR

Item 3 · From time to time, we are a party to legal proceedings arising in the ordinary course of business. We are not currently a party to any legal proceedings that we believe could have a material adverse effect on financial condition or results of operations.

Item 9A · ICFR · Based on our evaluation under this framework, our management concluded that our internal control over financial reporting was effective as of June 30, 2024.

Item 9A · disclosure controls · Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures are effective as of June 30, 2024.

Item 9A · material weakness · Management has remediated the previously identified material weakness by maintaining effective procedures pertaining to the timely review of the Form 10-K.

2023-06-302023-10-13none statedNOT effectiveNOT effectivedisclosedEDGAR

Item 3 · From time to time, we are a party to legal proceedings arising in the ordinary course of business. We are not currently a party to any legal proceedings that we believe could have a material adverse effect on financial condition or results of operations.

Item 9A · ICFR · Based on our evaluation under this framework, our management concluded that our internal control over financial reporting was not effective as of June 30, 2023 due to the material weakness described below: Management did not maintain effective procedures pertaining to the timely review of the Form 10-K.

Item 9A · disclosure controls · Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures are not effective as of June 30, 2023.

2022-06-302022-10-13as filedNOT effectiveNOT effectivedisclosedEDGAR

Item 3 · From time to time, we are a party to legal proceedings arising in the ordinary course of business. We are not currently a party to any other legal proceedings that we believe could have a material adverse effect on financial condition or results of operations.

Item 9A · ICFR · Based on our evaluation under this framework, our management concluded that our internal control over financial reporting was not effective as of June 30, 2022 due to the material weakness described below: Management did not maintain effective procedures pertaining to the review of the 10-K.

Item 9A · disclosure controls · Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures are not effective as of June 30, 2022 due to a material weakness in our internal control over financial reporting described below.

2021-06-302021-10-12as filedNOT effectiveNOT effectivedisclosedEDGAR

Item 3 · From time to time, we are a party to legal proceedings arising in the ordinary course of business. We are not currently a party to any other legal proceedings that we believe could have a material adverse effect on financial condition or results of operations.

Item 9A · ICFR · Based on our evaluation under this framework, our management concluded that our internal control over financial reporting was not effective as of June 30, 2021 due to the material weakness described below: Management did not maintain effective procedures pertaining to the review of the 10-K.

Item 9A · disclosure controls · Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the Company’s disclosure controls and procedures are not effective as of June 30, 2021 due to a material weakness in our internal control over financial reporting described below.

5 of 5 annual reports on record have their filing text cached on this host; the rest are listed with their EDGAR link and no extraction, because this surface never fetches from SEC on a page load.

  • Item 3 and Item 9A are located in the filing HTML already cached on this host and read with the same line-anchored item matcher and largest-gap body disambiguation the filing-narrative pass uses for Item 1A and Item 7 — no fetch, no model, no summarization.
  • A heading is accepted as a section only when it is not a table-of-contents row (a trailing page number), not a quoted reference in prose, and names its own section; the span must then clear a per-item length band and carry readable text after the heading. Anything that fails a gate is served as 'not extracted' with the reason — never as a default value.
  • An effectiveness conclusion is read only from a sentence that names its own control set (disclosure controls and procedures, or internal control over financial reporting) and states an outcome. Conditional sentences — the standard limitations paragraph and forward-looking remediation language — are excluded, because they are hypotheses rather than conclusions.
  • When a filing's own sentences disagree — an effective conclusion beside an unremediated material-weakness disclosure, or two conclusions of opposite sign — no verdict is asserted. A wrong 'controls were effective' reading is worse than no reading.
  • Every verdict is shown beside the verbatim sentence it was read from. The excerpt is the filing's own words, capped at 1,200 characters; the filing itself is one link away.